RAF1 and non-small cell lung carcinoma: Therefore, to investigate the effect of compound 0375-0604, we examined the phosphorylation levels of CRAF, AKT and ERK in NSCLC cell lines to monitor the impact of KRAS signaling by treatment with this compound for 48 h.